Chemomab Therapeutics's total assets for Q3 2025 were $12.37M, an increase of 11.13% from the previous quarter. CMMB total liabilities were $1.14M for the fiscal quarter, a -20.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.